Bexxar (TM) (tositumomab and iodine I 131 tositumomab) results in durable long-term responses in patients with poor prognosis, multiple relapsed (rel), and refractory (ref) low-grade or transformed low-grade non-Hodgkins lymphoma (NHL) Meeting Abstract
| Authors: | Leonard, J. P.; Zelenetz, A. D.; Vose, J. M.; Coleman, M.; Clapp, K. J.; Kaminski, M. S. |
| Abstract Title: | Bexxar (TM) (tositumomab and iodine I 131 tositumomab) results in durable long-term responses in patients with poor prognosis, multiple relapsed (rel), and refractory (ref) low-grade or transformed low-grade non-Hodgkins lymphoma (NHL) |
| Meeting Title: | 43rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 98 |
| Issue: | 11 Pt. 1 |
| Meeting Dates: | 2001 Dec 7-11 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2001-11-16 |
| Start Page: | 603a |
| Language: | English |
| ACCESSION: | WOS:000172134102534 |
| PROVIDER: | wos |
| PUBMED: | 11727739 |
| Notes: | Meeting Abstract: 2527 -- Source: Wos |
